Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04266301 |
|---|---|
| Brief Title: | Study of Efficacy and Safety of MBG453 in Combination With Azacitidine in Subjects With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomonocytic Leukemia-2 (CMML-2) (STIMULUS-MDS2) |
| First Submitted : | January 21, 2020 |
| First Submitted that Met QC Criteria : | February 10, 2020 |
| First Posted : | February 12, 2020 |
| Last Update Submitted that Met QC Criteria : | May 2, 2024 |
| Last Update Posted : | May 3, 2024 |